Management Strategies of Acute Retinal Necrosis: Current Perspectives
Brittany Powell, Daniel Wang, Stephanie Llop, Richard B Rosen Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, United StatesCorrespondence: Richard B RosenNew York Eye and Ear Infirmary of Mount Sinai, 310 East 14th Street, New York, NY 10003 Tel +1 212-979-4...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2020
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/1d948134bea8458bafd8a507afde993c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Brittany Powell, Daniel Wang, Stephanie Llop, Richard B Rosen Department of Ophthalmology, New York Eye and Ear Infirmary of Mount Sinai, New York, NY, United StatesCorrespondence: Richard B RosenNew York Eye and Ear Infirmary of Mount Sinai, 310 East 14th Street, New York, NY 10003 Tel +1 212-979-4288Fax +1 212-979-4268Email rrosen@nyee.eduAbstract: Acute retinal necrosis is a rare yet devastating disease, with significant ocular morbidity. Over the past several decades, initial treatment regimens have shifted from intravenous antivirals requiring hospital admission to the routine use of oral antivirals with intravitreal antivirals for immediate local control. Given the rarity of this disease process and a lack of large-scale research trials, debate continues over recommended practice guidelines. In this paper, we review current diagnostic criteria and recommend a treatment algorithm based on available evidence.Keywords: occlusive vasculitis, medical management, posterior uveitis |
|---|